tiprankstipranks
Trending News
More News >

Aspire Biopharma Strengthens Financial Position with Debentures

Story Highlights

PowerUp Acquisition Corp ( (PWUP) ) just unveiled an update.

Aspire Biopharma Holdings, Inc. recently entered into a Securities Purchase Agreement with Cobra Alternative Capital Strategies, LLC and Target Capital X LLC, resulting in the issuance of $3,750,000 in convertible debentures with a 20% original issue discount. The agreement, consummated on February 20, 2025, includes provisions for potential additional debentures and involves a security interest in all company assets. This move aligns with Aspire’s strategic efforts to secure funding for its operations, following its recent business combination with PowerUp Acquisition Corp., which transformed it from a shell company to an active entity, and signifies a step towards strengthening its financial position and executing its growth strategy.

More about PowerUp Acquisition Corp

Aspire Biopharma Holdings, Inc. is a biopharmaceutical company engaged in developing and marketing novel delivery mechanisms for drugs. The company focuses on innovative ‘do no harm’ drug technologies and operates in the biopharmaceutical industry.

YTD Price Performance: -46.06%

Average Trading Volume: 14,942

Technical Sentiment Consensus Rating: Strong Buy

See more insights into PWUP stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App